Related Experiment Video
Updated: Jun 23, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Molecular Basis of Synergistic Tau Amyloid Core Inhibition by K311/K353 Acetylation via Microsecond MD Simulations
Jiaxuan Wu1, Xinyu He1, Minghua Fu2
1Wisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
Abstract:
Neurofibrillary tangles, composed of aggregated Tau proteins, are a pathological hallmark of Alzheimer's disease (AD). Within these tangles, the amyloid core is primarily formed by the microtubule-binding (MTB) repeats. Although site-specific acetylation has been implicated in the regulation of Tau aggregation, the atomic-level mechanisms by which individual acetylation events modulate the structure and interactions of amyloid-forming motifs remain incompletely understood. In particular, whether dual acetylation events may act cooperatively during early Tau assembly is still unclear. In this study, we used microsecond-scale all-atom molecular dynamics simulations to systematically examine the dimerization dynamics of the four Tau MTB repeat homodimers (R1-R4). Our simulations suggest that the relatively higher aggregation propensity of R3 and R4 may be associated with amyloidogenic, β-sheet-prone core sequences, in which the key lysine residues K311 and K353 are located. Further analysis indicates that acetylation at these sites attenuates early Tau dimerization: K353 acetylation appears to moderately destabilize the R4 dimer through steric effects and the disruption of intrachain salt bridges, resulting in a more disordered conformational ensemble. K311 acetylation shows a more pronounced inhibitory effect on R3 dimerization by neutralizing the positive charge of K311 and weakening key interchain salt bridges and π-cation interactions associated with the PHF6 motif. Notably, dual acetylation of K311 and K353 in the R3-R4 dimer produces a stronger-than-additive reduction in β-sheet formation. This potential synergistic effect arises from the combined disruption of the hydrophobic core and distal electrostatic interaction networks. In summary, our results provide a molecular-level explanation for how acetylation at K311 and K353 cooperatively modulates Tau dimerization and early amyloid nucleation, offering mechanistic insight into the role of lysine acetylation in Tau aggregation.
Insights
Acetylation of Tau proteins at K311 and K353 inhibits early aggregation by disrupting dimerization. Dual acetylation shows synergistic effects, reducing beta-sheet formation and offering insight into Alzheimer
Area of Science:
- Biochemistry
- Neuroscience
- Computational Biology
Background:
- Neurofibrillary tangles, comprising aggregated Tau proteins, are key pathological markers of Alzheimer's disease (AD).
- The amyloid core of these tangles is mainly formed by Tau's microtubule-binding (MTB) repeats.
- The precise atomic mechanisms by which Tau acetylation regulates aggregation remain unclear, especially regarding cooperative effects of dual acetylation.
Purpose of the Study:
- To investigate the atomic-level mechanisms of Tau's MTB repeat dimerization.
- To determine how site-specific acetylation at K311 and K353 affects Tau dimerization and early amyloid formation.
- To explore potential cooperative effects of dual acetylation on Tau aggregation.
Main Methods:
- Microsecond-scale all-atom molecular dynamics simulations were employed.
- Systematic examination of dimerization dynamics for the four Tau MTB repeat homodimers (R1-R4).
- Analysis of structural changes, salt bridges, and hydrophobic interactions upon acetylation.
Main Results:
- R3 and R4 repeats exhibit higher aggregation propensity due to β-sheet-prone sequences containing K311 and K353.
- Acetylation at K353 moderately destabilizes the R4 dimer, increasing conformational disorder.
- Acetylation at K311 significantly inhibits R3 dimerization by disrupting salt bridges and π-cation interactions within the PHF6 motif.
- Dual acetylation of K311 and K353 exhibits a synergistic effect, markedly reducing β-sheet formation beyond additive inhibition.
Conclusions:
- Acetylation at K311 and K353 acts as a molecular brake on Tau dimerization and early amyloid nucleation.
- Dual acetylation provides a stronger-than-additive inhibitory effect on β-sheet formation, suggesting cooperative mechanisms.
- These findings offer mechanistic insights into how lysine acetylation regulates Tau aggregation in Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

